Emergent BioSolutions Inc. (EBS) Profit Margins
Over the twelve months to 2026-06-30, Emergent BioSolutions Inc. (EBS) had gross margin 55.9%, operating margin -8.6%, net margin -23.0%, free cash flow margin 11.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
EBSEmergent BioSolutions Inc.Follow EBS — free
—
Price chart with a free account
- Market cap
- 319.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 84.6% | 83.7% | 80.1% | 74.8% | 78.0% | 73.1% | 65.1% | 58.8% | 60.8% | 66.0% | 57.8% | 34.3% | 30.3% | 34.7% | 56.1% | 55.9% | |
| Operating margin | 11.7% | 10.6% | 13.7% | 22.1% | 28.9% | 21.6% | 22.2% | 11.5% | 10.3% | 27.8% | 19.2% | -15.2% | -69.2% | -10.4% | 13.5% | -8.6% | |
| Net margin | 8.4% | 8.3% | 10.0% | 9.1% | 12.8% | 10.6% | 14.7% | 8.0% | 4.9% | 19.4% | 12.4% | -18.9% | -72.5% | -18.3% | 7.1% | -23.0% | |
| FCF margin | -15.3% | -5.0% | 17.6% | 20.2% | -0.5% | -4.4% | 27.3% | -3.9% | 9.1% | 25.0% | 5.4% | -35.2% | -24.6% | 3.4% | 21.1% | 11.2% |
USD billions · SEC XBRL
Emergent BioSolutions Inc. — questions
- What is Emergent BioSolutions Inc.'s gross margin?
- 55.9% over the twelve months to 2026-06-30.
- What is Emergent BioSolutions Inc.'s operating margin?
- -8.6% over the twelve months to 2026-06-30.
- What is Emergent BioSolutions Inc.'s net profit margin?
- -23.0% over the twelve months to 2026-06-30.
Every figure on this page comes from Emergent BioSolutions Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.